Cargando…
Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527409/ https://www.ncbi.nlm.nih.gov/pubmed/33042054 http://dx.doi.org/10.3389/fmicb.2020.544490 |
_version_ | 1783589049377751040 |
---|---|
author | Batista, Viviane Lima da Silva, Tales Fernando de Jesus, Luís Cláudio Lima Coelho-Rocha, Nina Dias Barroso, Fernanda Alvarenga Lima Tavares, Laisa Macedo Azevedo, Vasco Mancha-Agresti, Pamela Drumond, Mariana Martins |
author_facet | Batista, Viviane Lima da Silva, Tales Fernando de Jesus, Luís Cláudio Lima Coelho-Rocha, Nina Dias Barroso, Fernanda Alvarenga Lima Tavares, Laisa Macedo Azevedo, Vasco Mancha-Agresti, Pamela Drumond, Mariana Martins |
author_sort | Batista, Viviane Lima |
collection | PubMed |
description | Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have been sought as a means to ameliorate, prevent, and treat this condition. Among the alternatives available to address this side effect of treatment with 5-FU, the most promising has been the use of probiotics, prebiotics, synbiotics, and paraprobiotics. This review addresses the administration of these “biotics” as a therapeutic alternative for intestinal mucositis caused by 5-FU. It describes the effects and benefits related to their use as well as their potential for patient care. |
format | Online Article Text |
id | pubmed-7527409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75274092020-10-09 Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis Batista, Viviane Lima da Silva, Tales Fernando de Jesus, Luís Cláudio Lima Coelho-Rocha, Nina Dias Barroso, Fernanda Alvarenga Lima Tavares, Laisa Macedo Azevedo, Vasco Mancha-Agresti, Pamela Drumond, Mariana Martins Front Microbiol Microbiology Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have been sought as a means to ameliorate, prevent, and treat this condition. Among the alternatives available to address this side effect of treatment with 5-FU, the most promising has been the use of probiotics, prebiotics, synbiotics, and paraprobiotics. This review addresses the administration of these “biotics” as a therapeutic alternative for intestinal mucositis caused by 5-FU. It describes the effects and benefits related to their use as well as their potential for patient care. Frontiers Media S.A. 2020-09-17 /pmc/articles/PMC7527409/ /pubmed/33042054 http://dx.doi.org/10.3389/fmicb.2020.544490 Text en Copyright © 2020 Batista, da Silva, de Jesus, Coelho-Rocha, Barroso, Tavares, Azevedo, Mancha-Agresti and Drumond. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Batista, Viviane Lima da Silva, Tales Fernando de Jesus, Luís Cláudio Lima Coelho-Rocha, Nina Dias Barroso, Fernanda Alvarenga Lima Tavares, Laisa Macedo Azevedo, Vasco Mancha-Agresti, Pamela Drumond, Mariana Martins Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis |
title | Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis |
title_full | Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis |
title_fullStr | Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis |
title_full_unstemmed | Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis |
title_short | Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis |
title_sort | probiotics, prebiotics, synbiotics, and paraprobiotics as a therapeutic alternative for intestinal mucositis |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527409/ https://www.ncbi.nlm.nih.gov/pubmed/33042054 http://dx.doi.org/10.3389/fmicb.2020.544490 |
work_keys_str_mv | AT batistavivianelima probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT dasilvatalesfernando probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT dejesusluisclaudiolima probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT coelhorochaninadias probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT barrosofernandaalvarengalima probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT tavareslaisamacedo probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT azevedovasco probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT manchaagrestipamela probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis AT drumondmarianamartins probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis |